Publikationen in Zusammenarbeit mit Forschern von Complexo Hospitalario Universitario de Santiago (112)

2024

  1. Der p 23 sensitization in patients with house dust mite respiratory allergy

    European Annals of Allergy and Clinical Immunology, Vol. 56, Núm. 2, pp. 79-85

  2. Evaluation of the Cytokine Response Induced by Specific Allergen Immunotherapy in Patients with Vespa velutina Anaphylaxis

    International Archives of Allergy and Immunology, Vol. 185, Núm. 5, pp. 456-459

  3. Safety of 300IR house dust mite sublingual tablet from pooled clinical trial and post-marketing data

    World Allergy Organization Journal , Vol. 17, Núm. 7

2023

  1. A Clustered Schedule for Venom Immunotherapy With a Depot Extract: Reaching the Target in 7 Days

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 5, pp. 395-397

  2. CHOICE international survey: Clusters of allergen immunotherapy prescription from French and Spanish cohorts

    World Allergy Organization Journal, Vol. 16, Núm. 6

  3. Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice: Methodology

    World Allergy Organization Journal, Vol. 16, Núm. 2

  4. Immunotherapy for asthma

    The Dangers of Allergic Asthma (Nova Science Publishers, Inc.), pp. 249-263

  5. Measuring adherence to inhaled control medication in patients with asthma: Comparison among an asthma app, patient self-report and physician assessment

    Clinical and Translational Allergy, Vol. 13, Núm. 2

  6. Prueba de activación de basófilos en el seguimiento de pacientes que reciben inmunoterapia con veneno de himenópteros: revisión de la evidencia actual

    Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993), Vol. 69, Núm. 3, pp. 125-137

  7. RNA viruses alter house dust mite physiology and allergen production with no detected consequences for allergenicity

    Insect Molecular Biology, Vol. 32, Núm. 2, pp. 173-186

  8. Symptoms of anxiety and depression in patients with persistent asthma: A cross-sectional analysis of the INSPIRERS studies

    BMJ Open, Vol. 13, Núm. 5

2022

  1. Asian hornet, vespa velutina lepeletier 1836 (Hym.: Vespidae), venom obtention based on an electric stimulation protocol

    Molecules, Vol. 27, Núm. 1

  2. Consistency of Determination of sIgE and the Basophil Activation Test in Vespa velutina nigrithorax Allergy

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 2, pp. 143-145

  3. Immunotherapy with Vespula venom for Vespa velutina nigrithorax anaphylaxis: Preliminary clinical and immunological results

    Clinical and Experimental Allergy

  4. Major Allergen Content in Allergen Immunotherapy Products: The Limited Value of Numbers

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 5, pp. 345-356

  5. Management of Double Sensitization to Vespids in Europe

    Toxins, Vol. 14, Núm. 2

  6. Real-life report of allergen immunotherapy management during the COVID-19 outbreak in France and Spain

    Clinical and Experimental Allergy

  7. The Asian wasp Vespa velutina nigrithorax: Entomological and allergological characteristics

    Clinical and Experimental Allergy, Vol. 52, Núm. 4, pp. 489-498

  8. What We Know about Sting-Related Deaths? Human Fatalities Caused by Hornet, Wasp and Bee Stings in Europe (1994–2016)

    Biology, Vol. 11, Núm. 2

2021

  1. A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

    Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 3, pp. 1020-1030.e10